Although miR-138 has not previously been analysed in breast tissue samples, on a cellular level it has been implicated as a tumour suppressor [19], [20], [21], potentially through targeting Neutrophil gelatinase-associated lipocalcin(NGAL) [19] or hTERT [21]. Here, LCN2 is linked to neoplasm.